Balasa Dinverno Foltz adds Penumbra Inc (PEN) to its portfolio

Penumbra Inc (PEN) : Balasa Dinverno Foltz added new position in Penumbra Inc during the most recent quarter end. The investment management firm now holds 79,944 shares of Penumbra Inc which is valued at $4,822,222 , the company said in a statement filed on Jul 14, 2016 with the SEC.Penumbra Inc makes up approximately 0.85% of Balasa Dinverno Foltz’s portfolio.

Other Hedge Funds, Including , Bnp Paribas Arbitrage Sa boosted its stake in PEN in the latest quarter, The investment management firm added 931 additional shares and now holds a total of 1,030 shares of Penumbra Inc which is valued at $62,305.

On the company’s financial health, Penumbra Inc reported $0.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on May 9, 2016. Analyst had a consensus of $-0.07. The company had revenue of $57.90 million for the quarter, compared to analysts expectations of $53.11 million. The company’s revenue was up 48.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.07 EPS.

Penumbra Inc. is an interventional therapies company that designs develops manufactures and markets medical devices. The Company has a portfolio of products that addresses medical conditions and clinical needs across two markets which includes neuro and peripheral vascular. Its neuro products include Neurovascular Access Neuron Access System BENCHMARK Intracranial Access System Penumbra System 3D Penumbra Coil 400 Penumbra SMART Coil and LIBERTY stent. The Company’s neuro surgical tools include Apollo System. Its peripheral vascular products include Ruby Coil System Penumbra Occlusion Device (POD) and Indigo System. Its products address conditions which include ischemic stroke and hemorrhagic stroke which involve blockage or rupture of blood vessels in the brain and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures which involve the use of medical devices to remove or treat blockages or ruptures of blood vessels.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Penumbra Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Penumbra Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.